• 7040 malaria professionals are enjoying the free benefits of MalariaWorld today

Open Access | Perspective: Extensive Drug Resistance in Malaria and Tuberculosis

Author(s): 
Chansuda Wongsrichanalai, Comments to Author Jay K. Varma, Jonathan J. Juliano, Michael E. Kimerling, and John R. MacArthur
Reference: 
Emerg Infect Dis, Volume 16, Number 7–July 2010
Contact email: 
cwongsrichanalai@usaid.gov

Drug resistance in malaria and in tuberculosis (TB) are major global health problems. Although the terms multidrug-resistant TB and extensively drug-resistant TB are precisely defined, the term multidrug resistance is often loosely used when discussing malaria. Recent declines in the clinical effectiveness of antimalarial drugs, including artemisinin-based combination therapy, have prompted the need to revise the definitions of and/or to recategorize antimalarial drug resistance to include extensively drug-resistant malaria. Applying precise case definitions to different levels of drug resistance in malaria and TB is useful for individual patient care and for public health.